Biogen Inc.
BIIB NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 29, 2026
ET
EPS Est.
2.94
EPS Actual
3.60
Revenue Est.
$2.46B
Revenue Actual
$2.74B
Next Earnings Report
Date
Oct 28, 2026 · Wed
ET Oct 28, 2026 · Wed
Time
10/28 10:00-13:30
Pre-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
2.03
Revenue Est.
$2.64B
Company Overview
Biogen Inc. (ticker BIIB) is listed on NASDAQ with a market cap of about $32.49B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), Pre-market, with consensus EPS of 2.03. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 15, 2023 → Jul 29, 2026
Feb 15, 2023Range: 1.99 ~ 5.47Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | 2.94 | Above forecast↑3.60 | $2.46B | $2.74B |
| Apr 29, 2026 | -- | 3.05 | Above forecast↑3.57 | $2.29B | $2.48B |
| Feb 6, 2026 | -- | 1.63 | Above forecast↑1.99 | $2.2B | $2.28B |
| Oct 30, 2025 | -- | 3.88 | Above forecast↑4.81 | $2.34B | $2.45B |
| Jul 31, 2025 | -- | 3.90 | Above forecast↑5.47 | $2.33B | $2.65B |
| May 1, 2025 | -- | 2.90 | Above forecast↑3.02 | $2.23B | $2.43B |
| Feb 12, 2025 | -- | 3.43 | Above forecast↑3.44 | $2.41B | $2.45B |
| Oct 30, 2024 | -- | 3.77 | Above forecast↑4.08 | $2.43B | $2.47B |
| Aug 1, 2024 | -- | 4.07 | Above forecast↑5.28 | $2.39B | $2.35B |
| Apr 24, 2024 | -- | 3.47 | Above forecast↑3.67 | $2.31B | $2.29B |
| Feb 13, 2024 | -- | 3.16 | Below forecast↓2.95 | $2.47B | $2.39B |
| Nov 8, 2023 | -- | 3.99 | Above forecast↑4.36 | $2.39B | $2.53B |
| Jul 25, 2023 | -- | 3.77 | Above forecast↑4.02 | $2.37B | $2.46B |
| Apr 25, 2023 | -- | 3.28 | Above forecast↑3.40 | $2.34B | $2.46B |
| Feb 15, 2023 | -- | 3.48 | Above forecast↑4.05 | $2.45B | $2.54B |
Original Filings (SEC)
Quarterly10-Q · 2026-07-29 ↗
Earnings Release8-K · 2026-07-29 ↗
Quarterly10-Q · 2026-04-29 ↗
Earnings Release8-K · 2026-04-29 ↗
Annual10-K · 2026-02-06 ↗
Earnings Release8-K · 2026-02-06 ↗
Quarterly10-Q · 2025-10-30 ↗
Earnings Release8-K · 2025-10-30 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
